{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:20:22Z","timestamp":1777947622444,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"GPC Pharma"},{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"WEST"},{"name":"GPC Pharma"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jgar.2020.01.003","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T16:37:10Z","timestamp":1580229430000},"page":"391-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Performance of disk diffusion and broth microdilution for fosfomycin susceptibility testing of multidrug-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1380-9824","authenticated-orcid":false,"given":"Mar\u00eda Fernanda","family":"Mojica","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa","family":"De La Cadena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristhian","family":"Hern\u00e1ndez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6413-5623","authenticated-orcid":false,"given":"Tobias Manuel","family":"Appel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian Jos\u00e9","family":"Pallares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Virginia","family":"Villegas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2020.01.003_bib0005","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMp1408040","article-title":"Antibiotic resistance\u2014problems, progress, and prospects","volume":"371","author":"Nathan","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2020.01.003_bib0010","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1749-6632.1974.tb43277.x","article-title":"The mechanism of action of fosfomycin (phosphonomycin)","volume":"235","author":"Kahan","year":"1974","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jgar.2020.01.003_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8912039","article-title":"Intravenous fosfomycin: an assessment of its potential for use in the treatment of systemic infections in Canada","volume":"2018","author":"Zhanel","year":"2018","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.jgar.2020.01.003_bib0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cmi.2016.12.005","article-title":"Intravenous fosfomycin\u2014back to the future. Systematic review and meta-analysis of the clinical literature","volume":"23","author":"Grabein","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 1","key":"10.1016\/j.jgar.2020.01.003_bib0025","doi-asserted-by":"crossref","first-page":"S528","DOI":"10.1093\/ofid\/ofx163.1375","article-title":"Intravenous fosfomycin (ZTI-01) for the treatment of complicated urinary tract infections (cUTI) including acute pyelonephritis (AP): results from a multi-center, randomized, double-blind Phase 2\/3 study in hospitalized adults (ZEUS)","volume":"4","author":"Kaye","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2020.01.003_bib0030","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10096-007-0456-4","article-title":"Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin","volume":"27","author":"Falagas","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2020.01.003_bib0035","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/AAC.50.1.368-370.2006","article-title":"In vitro activity of fosfomycin against extended-spectrum-\u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures","volume":"50","author":"de Cueto","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.01.003_bib0040","series-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2018"},{"key":"10.1016\/j.jgar.2020.01.003_bib0045","series-title":"Breakpoint tables for interpretation of MICs and zone diameters. Version 8.1, 2018","author":"European Committee on Antimicrobial Susceptibility Testing (EUCAST)","year":"2018"},{"key":"10.1016\/j.jgar.2020.01.003_bib0050","series-title":"Recommandations 2017","author":"Comit\u00e9 de l\u2019antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie (CA-SFM)","year":"2017"},{"key":"10.1016\/j.jgar.2020.01.003_bib0055","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard\u2014tenth edition","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2015"},{"key":"10.1016\/j.jgar.2020.01.003_bib0060","series-title":"Development of in vitro susceptibility testing criteria and quality control parameters; approved guideline\u2014third edition","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008"},{"key":"10.1016\/j.jgar.2020.01.003_bib0065","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1128\/AAC.02048-13","article-title":"Susceptibility of multiresistant Gram-negative bacteria to fosfomycin and performance of different susceptibility testing methods","volume":"58","author":"Perdig\u00e3o-Neto","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.01.003_bib0070","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4269\/ajtmh.18-0396","article-title":"Molecular characterization of extended-spectrum \u03b2-lactamase Enterobacteriaceae isolated from Egyptian patients with community- and hospital-acquired urinary tract infection","volume":"100","author":"Shash","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jgar.2020.01.003_bib0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1099\/jmm.0.000901","article-title":"Experiences in fosfomycin susceptibility testing and resistance mechanism determination in Escherichia coli from urinary tract infections in the UK","volume":"2","author":"Cottell","year":"2019","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jgar.2020.01.003_bib0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jgar.2018.11.004","article-title":"Antibiotic resistance of Escherichia coli from outpatient urinary tract infections in women in six European countries including Russia","volume":"17","author":"Ny","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jgar.2020.01.003_bib0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.diagmicrobio.2018.07.014","article-title":"Discrepancies in fosfomycin susceptibility testing of KPC-producing Klebsiella pneumoniae with various commercial methods","volume":"93","author":"Camarlinghi","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2020.01.003_bib0090","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1128\/AAC.01235-09","article-title":"In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and\/or colistin","volume":"54","author":"Endimiani","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.01.003_bib0095","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cmi.2016.12.022","article-title":"Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae","volume":"23","author":"Ballestero-T\u00e9llez","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2020.01.003_bib0100","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1128\/AAC.00589-13","article-title":"In vitro activity of fosfomycin against a collection of clinical Pseudomonas aeruginosa isolates from 16 Spanish hospitals: establishing the validity of standard broth microdilution as susceptibility testing method","volume":"57","author":"D\u00edez-Aguilar","year":"2013","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520300047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520300047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:55:46Z","timestamp":1761990946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716520300047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":20,"alternative-id":["S2213716520300047"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2020.01.003","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of disk diffusion and broth microdilution for fosfomycin susceptibility testing of multidrug-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2020.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}